AVDL AVADEL PHARMACEUTICALS PLC Investor Conferences 8-K Filing 2024 - Annual Meeting of Shareholders Avadel Pharmaceuticals held its 2024 Annual Meeting of Shareholders, where directors were elected, the appointment of Deloitte & Touche LLP as the independent registered public auditor was ratified, and the compensation of named executive officers was approved.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC